All these compounds have been shown to possess promising anticancer potential, however, unraveling the underlying mechanism by which their HDAC inhibitory activities induce or facilitate inhibition of cancer growth remains unclear, especially in the light of the differential expression of various HDACs in different tumors, non-specific therapeutic effect and the differential response of cancer cells to HDAC inhibitors10,11. The gene discussed is HDAC9; the disease is cancer.